TY - JOUR
T1 - Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis
AU - Salisbury, Margaret L.
AU - Gross, Barry H.
AU - Chughtai, Aamer
AU - Sayyouh, Mohamed
AU - Kazerooni, Ella A.
AU - Bartholmai, Brian J.
AU - Xia, Meng
AU - Murray, Susan
AU - Myers, Jeffrey L.
AU - Lagstein, Amir
AU - Konopka, Kristine E.
AU - Belloli, Elizabeth A.
AU - Sheth, Jamie S.
AU - White, Eric S.
AU - Holtze, Colin
AU - Martinez, Fernando J.
AU - Flaherty, Kevin R.
N1 - Funding Information:
Acknowledgements: This study utilised data provided by the Lung Tissue Research Consortium supported by the National Heart, Lung, and Blood Institute.
Publisher Copyright:
© ERS 2018.
PY - 2018
Y1 - 2018
N2 - High-resolution computed tomography (HRCT) may be useful for diagnosing hypersensitivity pneumonitis. Here, we develop and validate a radiological diagnosis model and modelbased points score. Patients with interstitial lung disease seen at the University of Michigan Health System (derivation cohort) or enrolling in the Lung Tissue Research Consortium (validation cohort) were included. A thinsection, inspiratory HRCT scan was required. Thoracic radiologists documented radiological features. The derivation cohort comprised 356 subjects (33.9% hypersensitivity pneumonitis) and the validation cohort comprised 424 subjects (15.5% hypersensitivity pneumonitis). An age-, sex- and smoking statusadjusted logistic regression model identified extent of mosaic attenuation or air trapping greater than that of reticulation ("MA-AT>Reticulation"; OR 6.20, 95% CI 3.53-10.90; p<0.0001) and diffuse axial disease distribution (OR 2.33, 95% CI 1.31-4.16; p=0.004) as hypersensitivity pneumonitis predictors (area under the receiver operating characteristic curve 0.814). A model-based score >2 (1 point for axial distribution, 2 points for "MA-AT>Reticulation") has specificity 90% and positive predictive value (PPV) 74% in the derivation cohort and specificity 96% and PPV 44% in the validation cohort. Similar model performance is seen with population restriction to those reporting no exposure (score >2: Specificity 91%). When radiological mosaic attenuation or air trapping are more extensive than reticulation and disease has diffuse axial distribution, hypersensitivity pneumonitis specificity is high and false diagnosis risk low (<10%), but PPV is diminished in a low-prevalence setting.
AB - High-resolution computed tomography (HRCT) may be useful for diagnosing hypersensitivity pneumonitis. Here, we develop and validate a radiological diagnosis model and modelbased points score. Patients with interstitial lung disease seen at the University of Michigan Health System (derivation cohort) or enrolling in the Lung Tissue Research Consortium (validation cohort) were included. A thinsection, inspiratory HRCT scan was required. Thoracic radiologists documented radiological features. The derivation cohort comprised 356 subjects (33.9% hypersensitivity pneumonitis) and the validation cohort comprised 424 subjects (15.5% hypersensitivity pneumonitis). An age-, sex- and smoking statusadjusted logistic regression model identified extent of mosaic attenuation or air trapping greater than that of reticulation ("MA-AT>Reticulation"; OR 6.20, 95% CI 3.53-10.90; p<0.0001) and diffuse axial disease distribution (OR 2.33, 95% CI 1.31-4.16; p=0.004) as hypersensitivity pneumonitis predictors (area under the receiver operating characteristic curve 0.814). A model-based score >2 (1 point for axial distribution, 2 points for "MA-AT>Reticulation") has specificity 90% and positive predictive value (PPV) 74% in the derivation cohort and specificity 96% and PPV 44% in the validation cohort. Similar model performance is seen with population restriction to those reporting no exposure (score >2: Specificity 91%). When radiological mosaic attenuation or air trapping are more extensive than reticulation and disease has diffuse axial distribution, hypersensitivity pneumonitis specificity is high and false diagnosis risk low (<10%), but PPV is diminished in a low-prevalence setting.
UR - http://www.scopus.com/inward/record.url?scp=85054717974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054717974&partnerID=8YFLogxK
U2 - 10.1183/13993003.00443-2018
DO - 10.1183/13993003.00443-2018
M3 - Article
C2 - 29946001
AN - SCOPUS:85054717974
SN - 0903-1936
VL - 52
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 2
M1 - 1800443
ER -